Benjamin Wolozin1, Martin M Bednar. 1. Department of Pharmacology, Boston University School of Medicine, Boston, MA 02118-2526, USA. bwolozin@bu.edu
Abstract
OBJECTIVES: To review the contributions of cardiovascular disease to Alzheimer's disease and vascular dementia. METHODS: Review of the literature. RESULTS: Alzheimer's disease and vascular dementia both share significant risk attributable to cardiovascular risk factors. Hypertension and hypercholesterolemia at midlife are significant risk factors for both subsequent dementia. Diabetes and obesity are also risk factors for dementia. Stressful medical procedures, such as coronary artery bypass and graft operations also appear to contribute to the risk of Alzheimer's disease. Apolipoprotein E is the major risk factor for Alzheimer's disease. Apolipoprotein E does not appear to contribute to Alzheimer's disease by increasing serum cholesterol, but it might contribute to the disease through a mechanism involving both Abeta and an increase in neuronal vulnerability to stress. DISCUSSION: The strong association of cardiovascular risk factors with Alzheimer's disease and vascular dementia suggest that these diseases share some biologic pathways in common. The contribution of cardiovascular disease to Alzheimer's disease and vascular dementia suggest that cardiovascular therapies might prove useful in treating or preventing dementia. Antihypertensive medications appear to be beneficial in preventing vascular dementia. Statins might be beneficial in preventing the progression of dementia in subjects with Alzheimer's disease.
OBJECTIVES: To review the contributions of cardiovascular disease to Alzheimer's disease and vascular dementia. METHODS: Review of the literature. RESULTS:Alzheimer's disease and vascular dementia both share significant risk attributable to cardiovascular risk factors. Hypertension and hypercholesterolemia at midlife are significant risk factors for both subsequent dementia. Diabetes and obesity are also risk factors for dementia. Stressful medical procedures, such as coronary artery bypass and graft operations also appear to contribute to the risk of Alzheimer's disease. Apolipoprotein E is the major risk factor for Alzheimer's disease. Apolipoprotein E does not appear to contribute to Alzheimer's disease by increasing serum cholesterol, but it might contribute to the disease through a mechanism involving both Abeta and an increase in neuronal vulnerability to stress. DISCUSSION: The strong association of cardiovascular risk factors with Alzheimer's disease and vascular dementia suggest that these diseases share some biologic pathways in common. The contribution of cardiovascular disease to Alzheimer's disease and vascular dementia suggest that cardiovascular therapies might prove useful in treating or preventing dementia. Antihypertensive medications appear to be beneficial in preventing vascular dementia. Statins might be beneficial in preventing the progression of dementia in subjects with Alzheimer's disease.
Authors: Sudha Seshadri; Alexa Beiser; Margaret Kelly-Hayes; Carlos S Kase; Rhoda Au; William B Kannel; Philip A Wolf Journal: Stroke Date: 2006-01-05 Impact factor: 7.914
Authors: Eric B Larson; Li Wang; James D Bowen; Wayne C McCormick; Linda Teri; Paul Crane; Walter Kukull Journal: Ann Intern Med Date: 2006-01-17 Impact factor: 25.391
Authors: Linda Ferrington; J Scott Miners; Laura E Palmer; Susan M Bond; Joanne E Povey; Paul At Kelly; Seth Love; Karen J Horsburgh; Patrick G Kehoe Journal: Am J Transl Res Date: 2011-02-05 Impact factor: 4.060
Authors: Tyler A Kokjohn; Gregory D Van Vickle; Chera L Maarouf; Walter M Kalback; Jesse M Hunter; Ian D Daugs; Dean C Luehrs; John Lopez; Daniel Brune; Lucia I Sue; Thomas G Beach; Eduardo M Castaño; Alex E Roher Journal: Biochim Biophys Acta Date: 2011-07-20
Authors: Alex E Roher; Chera L Esh; Tyler A Kokjohn; Eduardo M Castaño; Gregory D Van Vickle; Walter M Kalback; R Lyle Patton; Dean C Luehrs; Ian D Daugs; Yu-Min Kuo; Mark R Emmerling; Holly Soares; Joseph F Quinn; Jeffrey Kaye; Donald J Connor; Nina B Silverberg; Charles H Adler; James D Seward; Thomas G Beach; Marwan N Sabbagh Journal: Alzheimers Dement Date: 2009-01 Impact factor: 21.566
Authors: Sonia Franciosi; Miguel A Gama Sosa; Daniel F English; Elizabeth Oler; Twethida Oung; William Gm Janssen; Rita De Gasperi; James Schmeidler; Dara L Dickstein; Christoph Schmitz; Sam Gandy; Patrick R Hof; Joseph D Buxbaum; Gregory A Elder Journal: Mol Neurodegener Date: 2009-10-24 Impact factor: 14.195